Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
Howard M KatzensteinMarcio H MalogolowkinMark D KrailoJin PiaoAlexander J TowbinM Beth McCarvilleGregory M TiaoStephen P DunnMax R LanghamEugene D McGahrenMilton J FinegoldSarangarajan RanganathanChristopher B WeldonPatrick A ThompsonAngela D Trobaugh-LotrarioAllison F O'NeillWayne L FurmanNadia ChungJessica RandazzoCarlos Rodriguez-GalindoRebecka L MeyersPublished in: Cancer (2021)
The addition of doxorubicin to the previous standard regimen of C5V is feasible, tolerable, and efficacious, and this suggests that C5VD is a good regimen for future clinical trials.